Daniel Grosslight
Stock Analyst at Citigroup
(1.88)
# 3,122
Out of 4,667 analysts
96
Total ratings
35.29%
Success rate
-9%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MCK McKesson | Maintains: Buy | $630 → $713 | $621.14 | +14.79% | 6 | Nov 13, 2024 | |
| HCAT Health Catalyst | Maintains: Buy | $9 → $11 | $7.36 | +42.66% | 7 | Nov 13, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $10 → $7 | $4.31 | +62.41% | 6 | Nov 13, 2024 | |
| EVH Evolent Health | Maintains: Buy | $33 → $21 | $11.31 | +85.68% | 3 | Nov 13, 2024 | |
| AGL agilon health | Maintains: Sell | $2.5 → $1.75 | $1.67 | +4.79% | 3 | Nov 13, 2024 | |
| OMI Owens & Minor | Maintains: Buy | $21 → $19 | $11.89 | +55.59% | 5 | Nov 5, 2024 | |
| MPLN MultiPlan | Maintains: Neutral | $17 → $10 | $6.45 | +55.04% | 8 | Sep 23, 2024 | |
| CAH Cardinal Health | Maintains: Neutral | $115 → $107 | $120.34 | -11.09% | 4 | Jul 19, 2024 | |
| HIMS Hims & Hers Health | Downgrades: Neutral | $16 → $20 | $21.79 | -8.21% | 6 | May 22, 2024 | |
| PRVA Privia Health Group | Initiates: Buy | $25 | $20.79 | +20.25% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $9.4 | $3.15 | +198.41% | 10 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $19 | $9.00 | +111.11% | 10 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $37 | $18.52 | +99.78% | 5 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $5.13 | +94.93% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $12.22 | -34.53% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $2.55 | -50.98% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $3.16 | +10.76% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $9.72 | +33.74% | 1 | Dec 11, 2019 |
McKesson
Nov 13, 2024
Maintains: Buy
Price Target: $630 → $713
Current: $621.14
Upside: +14.79%
Health Catalyst
Nov 13, 2024
Maintains: Buy
Price Target: $9 → $11
Current: $7.36
Upside: +42.66%
GoodRx Holdings
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $7
Current: $4.31
Upside: +62.41%
Evolent Health
Nov 13, 2024
Maintains: Buy
Price Target: $33 → $21
Current: $11.31
Upside: +85.68%
agilon health
Nov 13, 2024
Maintains: Sell
Price Target: $2.5 → $1.75
Current: $1.67
Upside: +4.79%
Owens & Minor
Nov 5, 2024
Maintains: Buy
Price Target: $21 → $19
Current: $11.89
Upside: +55.59%
MultiPlan
Sep 23, 2024
Maintains: Neutral
Price Target: $17 → $10
Current: $6.45
Upside: +55.04%
Cardinal Health
Jul 19, 2024
Maintains: Neutral
Price Target: $115 → $107
Current: $120.34
Upside: -11.09%
Hims & Hers Health
May 22, 2024
Downgrades: Neutral
Price Target: $16 → $20
Current: $21.79
Upside: -8.21%
Privia Health Group
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $20.79
Upside: +20.25%
Apr 16, 2024
Maintains: Neutral
Price Target: $17 → $9.4
Current: $3.15
Upside: +198.41%
Feb 21, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $9.00
Upside: +111.11%
Sep 7, 2023
Maintains: Buy
Price Target: $40 → $37
Current: $18.52
Upside: +99.78%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $5.13
Upside: +94.93%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $12.22
Upside: -34.53%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $2.55
Upside: -50.98%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $3.16
Upside: +10.76%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $9.72
Upside: +33.74%